Biggest News Aggregation in the World
📰 Phase News

Page 1483 - Phase News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Phase. Real-time updates on events, politics, business and more.

Update on the design of a Phase III Precision Medicine trial with the Diabetes Vaccine Diamyd

Update on the design of a Phase III Precision Medicine trial with the Diabetes Vaccine Diamyd The upcoming Phase III trial with Diamyd in new-onset type 1 diabetes will be based on the first precision medicine approach in the field. The trial is designed to confirm the effect and safety of Diamyd in individuals recently diagnosed with type 1 diabetes who carry the genetic HLA DR3-DQ2 haplotype. The Phase III trial is designed to enroll approximately 330 individuals aged 12 to 28, recently d...
United States Uppsala Lan Ulf Hannelius European Medicinal Authority Health Technology Assesment Drug Administration

Salvadoran press highlights Cuba's Covid-19 vaccine trials

Salvadoran press highlights Cubas Covid-19 vaccine trials Salvadoran press highlights Cubas Covid-19 vaccine trials San Salvador, Mar 4 (Prensa Latina) Progress in clinical trials for the Cuban Soberana 02 vaccine project against the SARS-CoV-2 coronavirus, which causes Covid-19, was highlighted on Salvadoran CoLatino daily on Thursday. The oldest printed daily in El Salvador reported the authorization of the third phase of clinical trials of this vaccine candidate, developed by the Finlay Inst...
San Salvador El Salvador New York United States Dagoberto Gutierrez Temas Relacionados

GoldHaven Resources Corp.: GoldHaven Provides Drilling Update on Rio Loa and Prepares for First Phase Drilling at Alicia

(2) Vancouver, British Columbia--(Newsfile Corp. - March 4, 2021) - GoldHaven Resources Corp. (CSE: GOH) (OTCQB: GHVNF) (FSE: 4QS) ("GoldHaven", "GOH" or the "Company") reports that Phase I drilling continues to advance as planned at Rio Loa. The Rio Loa Project is located 25 km south of Gold Fields Salares Norte deposit (5.2 million ounces equivalent of Gold scheduled to produce 450,000oz of Gold per annum 1) and 6 km south of Gold Fields Horizonte discovery. The GOH drill-team is actively d...
La Coipa Iii Region United States United Kingdom British Columbia Perth And Kinross

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

Aztec Minerals Corp.: Aztec and Tombstone Partners Plan Two Phase, CAD$1.5 Million Exploration Program in 2021 at Tombstone Project, Arizona

(2) VANCOUVER, BC / ACCESSWIRE / March 4, 2021 / Aztec Minerals Corp. (TSXV:AZT)(OTCQB:AZZTF) and Tombstone Gold & Silver Inc. and Tombstone Resources Inc. (collectively, "Tombstone Partners") plan a two-phase, CAD$1.51 million exploration program in 2021 for the Tombstone Property located in Cochise County, Arizona. Aztec (75%) and Tombstone Partners (25%) recently formed a 75/25 joint venture ("JV") and the JV Management Committee met last week to review and approve the following two-phase e...
United States British Columbia Bradford Cooke Joey Wilkins Simon Dyakowski Tombstone Gold Silver Inc

TurnSole Biologics: TurnSole Announces Regulatory Authority Approval and Subsequent Initiation of a Phase Ib/II Trial to evaluate the efficacy and the safety of TS-020 in acute COVID-19 viral infection in Patients with Severe Infection with Risk of Progre

(1) PÉCS, Hungary and BUDAPEST, Hungary, March 04, 2021 (GLOBE NEWSWIRE) -- TurnSole Biologics (TurnSole) today announced the start of a Phase I/II open-label study for Azacytidine, initiated with a lead-in dose escalation pharmacokinetic Phase I/b part in the 20-50 mg/m2 range to evaluate safety in Hospitalized COVID-19 Patients in Severe Infection with Risk of Progression as Add-on Therapy to Standard of Care, continued with a Randomized, Controlled, Open-Label Adaptive Phase II part to De...
Gabor Heltovics Kostenloser Wertpapierhandel Tibor Rauch Sole Biologics Severe Infection Add On Therapy

Nordic Bioscience Welcomes Investment from KKR for Next Phase of Growth

Nordic Bioscience Welcomes Investment from KKR for Next Phase of Growth KKRs investment will support Nordic Bioscience with commercialization and the global expansion of its R&D services, diagnostics platform, leading patent portfolio and drug development pipeline Nordic Bioscience A/S, a Danish company and world leader in biomarker development, announced today the signing of an investment from KKR, a leading global investment firm. KKR will acquire a minority equity stake in Nordic Bioscience ...
Bente Juel Riis Alastair Elwen Alice Neave Morten Karsdal Kugan Sathiyanandarajah Anders Borg Claus Christiansen

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science